Acquisition by Dawn Svoronos of 18475 shares of Xenon Pharmaceuticals subject to Rule 16b-3
| TH Stock | CAD 1.70 0.02 1.19% |
About 51% of Theratechnologies' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Theratechnologies suggests that some traders are interested. Theratechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Theratechnologies. Many technical investors use Theratechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theratechnologies |
Filed transaction by Xenon Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Theratechnologies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Theratechnologies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Theratechnologies is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| ROOF | Northstar Clean | 3.57 | ||||
| FN-PB | First National | 0.82 | ||||
| LB | Laurentian Bank | 0.51 | ||||
| AWI | Advent Wireless | 0.00 | ||||
| IFC-PG | Intact Financial | 0.12 | ||||
| OLY | Olympia Financial | 0.65 | ||||
| HD | HOME DEPOT | 1.08 | ||||
| TF | Timbercreek Financial | 1.16 |
Check out Theratechnologies Hype Analysis, Theratechnologies Correlation and Theratechnologies Performance. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.